Stay updated on Exebacase in COVID-19 MRSA Clinical Trial
Sign up to get notified when there's something new on the Exebacase in COVID-19 MRSA Clinical Trial page.

Latest updates to the Exebacase in COVID-19 MRSA Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page’s footer revision label was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record for exebacase expanded access in COVID-19 patients with persistent MRSA bacteremia is available, with its treatment details, eligibility criteria, locations, and record dates. The prior NIH notice and 403 error page are no longer shown.SummaryDifference29%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Exebacase in COVID-19 MRSA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exebacase in COVID-19 MRSA Clinical Trial page.